King's College London

Gammadelta Therapeutics Ltd

Cancer Research Technology Limited

The Francis Crick Institute Limited

Oliver Nussbaumer

Adrian Hayday

Mihriban Tuna

Richard Woolf

Natalie Mount

Maria Luisa Iannitto

Richard Esmond Beatson

Mark Uden

Raj Mehta

Richard Beatson

Andrew Hutton

Joshua Freedman

Daisy Melandri

Adam Laing

Robin John Campbell Dart

Iva Zlatareva

Kalle Soderstrom

Louisa Mathias

Samuel Florence

Shristi Bhandari

Oxana Polyakova

Pierre Vantourout

Robert Good

Shefali Bhumbra

Irene Pizzitola

István KOVÁCS

The present invention provides methods of expanding γδ T cells from a non-haematopoietic tissue source. Further provided are compositions of expanded γδ T cells and methods of using the expanded γδ T cells (e.g., a part of an adoptive T cell therapy).

Expansion of γδ T cells, compositions, and methods of use thereof

The present invention relates to a method for the isolation of lymphocytes (in particular γδ T cells) from a non-haematopoietic tissue sample comprising the steps of culturing a non-haematopoietic tissue sample which is an intact biopsy obtained from a non-haematopoietic tissue in the presence of Interleukin-2 (IL-2) and Interleukin-15 (IL-15); and collecting a population of lymphocytes cultured from the non-haematopoietic tissue sample. Methods of subsequent expansion are provided, as well as populations of isolated cells obtained by the method and uses thereof.

Methods for isolating and expanding cells

Protein constructs comprising a BTNL3/8 targeting moiety, a payload and an optional linker are described herein. Pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.

BTNL3/8 targeting constructs for delivery of payloads

The present invention provides methods of expanding &#x3b3;&#x3b4; T cells from a non-haematopoietic tissue source. Further provided are compositions of expanded &#x3b3;&#x3b4; T cells and methods of using the expanded &#x3b3;&#x3b4; T cells (e.g., apart of an adoptive T cell therapy).

Expansion of &#x3b3;&#x3b4; T cells, compositions, and methods of use thereof

This invention relates to the expansion of non-haematopoietic tissue-resident &#x3b3;&#x3b4; T cells in vitro by culturing lymphocytes obtained from non-haematopoietic tissue of humans or non-human animals in the presence of interleukin-2 (IL-2) and/or interleukin-15 (IL-15) and the absence of TCR activation or co-stimulation signals, without any direct contact with stromal or epithelial cells. Methods of non-haematopoietic tissue-resident &#x3b3;&#x3b4; T cell expansion are provided, as well as populations of non-haematopoietic tissue-resident &#x3b3;&#x3b4; T cells and uses thereof.

Expansion of non-haematopoietic tissue-resident gamma delta T cells and uses of these cells

Growing community of inventors

London, United Kingdom

Oliver Nussbaumer